Forty-five jobs are to be created at a biopharmaceutical company in west Dublin.
Mallinckrodt is to create the jobs at a new €45m plant in Blanchardstown's College Business and Technology Park.
Some 300 jobs will be created in the two-year construction phase.
Mallinckrodt employs more than 120 people at its existing manufacturing site in Dublin.
This investment brings Mallinckrodt Pharmaceuticals’ investment in Ireland to more than €165m in the last 22 years.
The company provides treatment options for patients with a wide variety of health conditions, with a particular focus on autoimmune and rare diseases, analgesia, neonatal critical care respiratory therapies, and central nervous system disorders.